Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients

This study has been terminated.
Brookdale University Hospital Medical Center
Josephine Ford Cancer Center
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: July 16, 2002
Last updated: July 27, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2005
  Primary Completion Date: January 2005 (Final data collection date for primary outcome measure)